Notizie AIOM – anno XVII – Pagina 26

17 Settembre 2019

Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care

Despite recent advances in thoracic oncology, most patients with metastatic lung cancer die within months of diagnosis. Aggressiveness of their end-of-life (EOL) care has been the subject of numerous studies. This study was undertaken to evaluate the literature on aggressive ...
Leggi tutto

16 Settembre 2019

FDA Issues Warning on Severe Lung Inflammation With CDK4/6 Inhibitors in Breast Cancer

Sep 13, 2019 - The FDA is updating the prescribing information and Patient Package Insert for the CDK4/6 inhibitors palbociclib, ribociclib, and abemaciclib to include a warning that the treatments in rare cases may cause severe inflammation of the lungs. The inflammation ...
Leggi tutto

16 Settembre 2019

13 settembre 2019 – Comunicazione EMA sui medicinali a base di ranitidina

16 Settembre 2019

13 settembre 2019 – Attivazione del Registro Dabrafenib (Novartis) in monoterapia o in associazione con Trametinib (Novartis)

16 Settembre 2019

EMA to provide guidance on avoiding nitrosamines in human medicines

Sep 13, 2019 - EMA’s Executive Director has asked the human medicines committee (CHMP) to provide guidance for avoiding the presence of nitrosamine impurities in human medicines containing chemically synthesised active substances. 'We will continue to work with our ...
Leggi tutto

13 Settembre 2019

13 settembre 2019 – Comunicazione EMA sulle impurezze nitrosamminiche

13 Settembre 2019

Statement on improving adverse event reporting of compounded drugs to protect patients

Sep 9, 2019 - Compounded drugs can serve an important medical need for certain patients, however, they also present risks to patients since they are not evaluated by the FDA for safety, effectiveness and quality. The FDA’s compounding program aims to help protect patients ...
Leggi tutto

13 Settembre 2019

Congress Must Improve Prior Authorization to Ensure People With Cancer Have Timely Access to Care

Sep 10, 2019 - The American Society of Clinical Oncology (ASCO) joined approximately 350 health care groups in urging members of the U.S. House of Representatives to support the Improving Seniors’ Timely Access to Care Act (H.R. 3107). The bipartisan bill would help ...
Leggi tutto

13 Settembre 2019

Trump Administration Combating Epidemic of Youth E-Cigarette Use with Plan to Clear Market of Unauthorized, Non-Tobacco-Flavored E-Cigarette Products

Sep 11, 2019 - Today, the Trump Administration announced that as part of its ongoing work to tackle the epidemic of youth e-cigarette use, the FDA intends to finalize a compliance policy in the coming weeks that would prioritize the agency’s enforcement of the premarket ...
Leggi tutto

13 Settembre 2019

Safety of pregnancy following breast cancer (BC) in patients (pts) carrying a BRCA mutation (mBRCA): Results of an international cohort study

Very limited data are available on the safety of pregnancy and reproductive outcomes in mBRCA pts with prior BC history. We report the results of the largest study to date addressing these questions. This international, multicenter, hospital-based, retrospective cohort study ...
Leggi tutto

LAVORIAMO CON

News

TUMORI: “AIFA APPROVA LA FORMULAZIONE SOTTOCUTANEA E TRE NUOVE INDICAZIONI TERAPEUTICHE DI NIVOLUMAB”

TUMORE AL SENO: METASTASI SI DIFFONDONO COME GOCCE SU UNA SUPERFICIE. LA CAPACITÀ INVASIVA DIPENDE DALLA “FLUIDITÀ” DEL CANCRO

ONE HEALTH FOUNDATION: AL VIA IL PROGETTO IN 36 CENTRI ESTIVI IN ALBANIA. SULLA “NAVE DELLA SALUTE” SVOLTI PIU’ DI 550 TEST E VISITE MEDICHE

AL VIA LA TERZA EDIZIONE DELLA “NAVE DELLA SALUTE” ITALIA-ALBANIA. LA PREVENZIONE SALE A BORDO CON 17 MEDICI SPECIALISTI E 10 AMBULATORI

TOVORAFENIB È LA PRIMA TERAPIA MIRATA APPROVATA IN EUROPA NEL GLIOMA PEDIATRICO DI BASSO GRADO RECIDIVATO O REFRATTARIO, INDIPENDENTEMENTE DAL TIPO DI ALTERAZIONE DI BRAF

TOZORAKIMAB HA SODDISFATTO L’ENDPOINT PRIMARIO DELLO STUDIO DI FASE III MIRANDA NEI PAZIENTI CON BPCO

MIASTENIA GRAVIS, 15MILA PERSONE COLPITE IN ITALIA. “UN’INSTALLAZIONE IMMERSIVA PER COMPRENDERE LA VITA DEI PAZIENTI E AUMENTARE LA CONSAPEVOLEZZA”

Notizie AIOM – anno XVII

Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care

FDA Issues Warning on Severe Lung Inflammation With CDK4/6 Inhibitors in Breast Cancer

13 settembre 2019 – Comunicazione EMA sui medicinali a base di ranitidina

13 settembre 2019 – Attivazione del Registro Dabrafenib (Novartis) in monoterapia o in associazione con Trametinib (Novartis)

EMA to provide guidance on avoiding nitrosamines in human medicines

13 settembre 2019 – Comunicazione EMA sulle impurezze nitrosamminiche

Statement on improving adverse event reporting of compounded drugs to protect patients

Congress Must Improve Prior Authorization to Ensure People With Cancer Have Timely Access to Care

Trump Administration Combating Epidemic of Youth E-Cigarette Use with Plan to Clear Market of Unauthorized, Non-Tobacco-Flavored E-Cigarette Products

Safety of pregnancy following breast cancer (BC) in patients (pts) carrying a BRCA mutation (mBRCA): Results of an international cohort study